Free Trial

Forian (FORA) Competitors

$2.77
-0.01 (-0.36%)
(As of 06/7/2024 08:52 PM ET)

FORA vs. YI, LAZY, POET, WILC, ACONW, BTSGU, BFRGW, CCLDP, CCLDO, and CMAXW

Should you be buying Forian stock or one of its competitors? The main competitors of Forian include 111 (YI), Lazydays (LAZY), POET Technologies (POET), G. Willi-Food International (WILC), Aclarion (ACONW), BrightSpring Health Services (BTSGU), Bullfrog AI (BFRGW), CareCloud (CCLDP), CareCloud (CCLDO), and CareMax (CMAXW).

Forian vs.

111 (NASDAQ:YI) and Forian (NASDAQ:FORA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking.

In the previous week, Forian had 1 more articles in the media than 111. MarketBeat recorded 1 mentions for Forian and 0 mentions for 111. Forian's average media sentiment score of 0.00 equaled 111'saverage media sentiment score.

Company Overall Sentiment
111 Neutral
Forian Neutral

Forian has a consensus price target of $7.67, indicating a potential upside of 176.77%. Given 111's higher possible upside, analysts plainly believe Forian is more favorable than 111.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
111
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Forian
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

111 received 181 more outperform votes than Forian when rated by MarketBeat users. However, 90.00% of users gave Forian an outperform vote while only 61.69% of users gave 111 an outperform vote.

CompanyUnderperformOutperform
111Outperform Votes
190
61.69%
Underperform Votes
118
38.31%
ForianOutperform Votes
9
90.00%
Underperform Votes
1
10.00%

Forian has lower revenue, but higher earnings than 111. 111 is trading at a lower price-to-earnings ratio than Forian, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
111$2.11B0.05-$43.07M-$0.62-1.81
Forian$20.49M4.21$3.11M$0.1027.70

Forian has a net margin of 0.00% compared to Forian's net margin of -2.55%.

Company Net Margins Return on Equity Return on Assets
111-2.55% N/A -12.13%
Forian N/A N/A N/A

111 has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Forian has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500.

21.3% of 111 shares are held by institutional investors. Comparatively, 19.3% of Forian shares are held by institutional investors. 43.9% of 111 shares are held by company insiders. Comparatively, 31.3% of Forian shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Forian beats 111 on 11 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FORA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FORA vs. The Competition

MetricForianHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market Cap$86.26M$198.09M$5.27B$8.17B
Dividend YieldN/A6.61%2.77%4.05%
P/E Ratio27.70436.32137.3818.10
Price / Sales4.21604.382,448.4577.66
Price / CashN/A47.1435.7130.66
Price / BookN/A4.424.994.32
Net Income$3.11M-$9.74M$110.97M$216.21M
7 Day Performance6.95%-0.25%-1.09%-1.44%
1 Month Performance-1.07%3.59%-0.96%-0.97%
1 Year Performance14.94%-4.69%4.12%4.10%

Forian Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YI
111
0 of 5 stars
$1.12
-1.8%
N/A-59.9%$95.78M$2.11B-1.811,520
LAZY
Lazydays
0 of 5 stars
N/A$13.67
+∞
N/A$74.92M$1.33B-6.941,400
POET
POET Technologies
1.0466 of 5 stars
$1.72
-3.4%
$7.50
+336.0%
-65.6%$104.22M$470,000.00-3.5153
WILC
G. Willi-Food International
0 of 5 stars
$9.41
flat
N/A-26.9%$130.52M$149.78M11.91207Positive News
ACONW
Aclarion
0 of 5 stars
$0.04
-62.5%
N/A-74.9%$0.00$60,048.000.004Gap Down
High Trading Volume
BTSGU
BrightSpring Health Services
0 of 5 stars
$44.86
-3.4%
N/AN/A$0.00$9.37B0.0035,000Gap Down
BFRGW
Bullfrog AI
0 of 5 stars
$0.42
-6.7%
N/A-42.7%$0.00$65,000.000.002Gap Down
CCLDP
CareCloud
0 of 5 stars
$12.45
-2.4%
N/A-54.0%$0.00$113.02M0.003,600
CCLDO
CareCloud
0 of 5 stars
$13.53
+1.5%
N/A-39.4%$0.00$113.02M0.003,600
CMAXW
CareMax
0 of 5 stars
$0.01
flat
N/AN/A$0.00$810.37M0.001,450

Related Companies and Tools

This page (NASDAQ:FORA) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners